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ABSTRACT 
 This thesis provides a decision analytic framework for calculating the medical costs 
associated with the decision to consume sugar-sweetened beverages.  The model uses (i) records 
of mortality data, (ii) previously identified lifetime risks of diabetes, (iii) data on relative risks 
associated with sugar-sweetened beverage consumption, and (iv) the reported costs of diabetes 
medical treatment to determine the increase in expected costs that result from the consumption 
decision.  Additionally the model can be used to analyze any decision that increases one’s 
relative risk of diabetes.   
 The results indicate that sugar-sweetened beverage consumption is considerably more 
costly for younger individuals than for older individuals.  Moreover, the frequency of beverage 
consumption also has a significant impact on expected medical costs.  These results have wide 
ranging implications for such areas as health insurance, national health spending, and public 
health awareness campaigns.  
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1. BACKGROUND AND MOTIVATION 
 
1.1  INTRODUCTION 
Diabetes affects 25.8 million Americans, over 8% of the population, with almost 2 
million new diagnoses in 2010 [1].  These numbers are sobering given the fact that diabetes is 
the leading cause of blindness, non-traumatic lower limb amputation, and kidney failure and that 
diabetes is the seventh leading cause of death in the U.S. [1].   
Lifestyle choices are pivotal in the prevention and management of diabetes.  Research has 
shown that the majority of type-2 diabetes cases could have been prevented through different 
lifestyle choices [2]. While clear recommendations exist on diets to minimize the risk of diabetes 
[3], the cost of these decisions as quantified in terms of their effects on increased expected 
lifetime medical expenditures has not been described.  A framework for determining the cost of 
lifestyle decisions related to diabetes would allow for insights into a wide range of problems, 
including planning public health awareness campaigns.  This chapter describes a model that 
enables just such an analysis with the goal of helping individuals better understand the impact of 
their lifestyle decisions. 
 The development of a model for lifestyle decisions in diabetes follows in the footsteps of 
other models that have quantified preferences for life and health states.  Howard created the 
concept of a micromort, a one-in-a-million chance of death, and describes the price to pay for 
accepting or avoiding a given number of micromorts [4].  Several authors have used quality-
adjusted-life-years (QALY’s) to develop consumption planning models that incorporate 
preferences for health [5, 6, 7]. Others have used QALY’s for medical decision making purposes, 
although the model has been criticized for oversimplifying preferences and failing to incorporate 
2 
 
potentially important factors [8].  Hazen incorporates preferences for lifetime milestones that 
may be independent of length of life to advance the QALY model [9]. 
 The cumulative impact of lifestyle decisions is tremendous.  Keeney conducts an analysis 
of mortality data in the United States that shows that personal decisions are in fact the leading 
cause of death [10].  This frame underscores the importance of the present model describing the 
impact of beverage choices on the risk diabetes and the subsequent effects on medical costs.  The 
focus on diabetes is motivated by the significant health impacts it poses, and on the fact that 
one’s risk is strongly associated with lifestyle choices.  
The following thesis analyzes personal decisions that affect one’s chances of being 
diagnosed with diabetes.  A framework is developed that enables the determination of values 
related to personal decision making and diabetes.  The remainder of this chapter provides the 
requisite knowledge for understanding how the model is developed.  Section 1.2 describes the 
Cox proportional hazards model.  Section 1.3 explains how behaviors can be linked to increases 
in the relative risk of diabetes.  Section 1.4 presents the baseline risk of diabetes.  Section 1.5 
describes mortality rates and how they are affected by diabetes.  Section 1.6 presents the 
financial costs associated with diabetes.  Finally, section 1.7 describes the research questions that 
are addressed by this thesis.  
 
1.2  COX PROPORTIONAL HAZARDS MODEL 
 The Cox proportional hazards model has been well studied in statistics and survival 
studies.  It is a useful tool that enables analysis of risks without requiring knowledge of the 
underlying hazard function [11, 12].  It is particularly useful in determining modified mortality 
probabilities given relative risks.   
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 In examining the effects of covariates, the values of the covariates, z, are known, but their 
effects are unknown parameters β.  Let the underlying, baseline hazard function be denoted 
.  To describe the effects of z, Cox uses the model 
  	 
 
where the underlying hazard function need not be known [11].  Given this model, the relative 
risk, R, of the value of one particular covariate to another can be determined by the ratio of the 
hazard associated with each as 
 	 

 
This formulation yields 
 	 
  . 
In the case where z is a single indicator variable with the values 0 and 1, the result is a constant 
hazard ratio, 
 	 
. 
 The importance of the Cox proportional hazards model to the current problem 
formulation is in the fact that relative risks are multiplied by a baseline hazard function to 
determine hazard as a function of a covariate.  The following section will describe research 
relative risks and diabetes.  The relative risk model presented will determine the relative risks 
that are multiplied by baseline risks to determine a decision maker’s risk of diabetes. 
 
1.3  RELATIVE RISKS OF DIABETES 
 Following the Cox proportional hazards model, the relative risk of diabetes for particular 
covariates can be determined.  Previous research has found increased relative risks for such 
covariates as body weight, smoking, family history, and diet [13, 14, 15].  Note that not all risk 
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factors for diabetes may be under one’s control, such as family history.  For the purposes of 
developing a model to evaluate the value of personal decisions, any of the covariates that are 
under an individual’s control may be chosen for analysis.   
 The consumption of sugar-sweetened beverages is one such personal decision that has 
been well studied in relation to its impact on the relative risk of diabetes mellitus. Several studies 
across different races, ethnicities, and gender have all found that consumption of sugar-
sweetened beverages is positively correlated with a diagnosis of diabetes [16, 17, 18].  Thus, 
while many behaviors affect one’s risk of diabetes and could be modeled, this framework 
focuses on the decision to consume sugar-sweetened beverages due to the existence of research 
on the impact of these specific decisions on relative risk as well as the prevalence of sugar-
sweetened beverages in society. The methodology developed herein presents a general 
framework that can be used to explore the effects of other lifestyle decisions as well.   
It is worthwhile to note that some of the research regarding sugar-sweetened beverages 
has been criticized for having too narrow a scope given that numerous behaviors affect the 
relative risk of diabetes [19].  The usefulness of the present personal decision making model as a 
framework for analyzing lifestyle decisions beyond those of beverage consumption must again 
be highlighted. 
 In order to quantify the effect of a decision on lifetime prospects due to diabetes, it is first 
necessary to derive the relationship between the decision in question and its effect on the relative 
risk of diabetes.  Such a relationship would need to satisfy certain assumptions.  The general 
properties assumed by the present model are explained below. 
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1. The absence of a risk inducing behavior results in no increase in relative risk. This 
assumption implies that the minimum relative risk is 1 if only those behaviors that 
increase risk are considered.  
2. The effect of a risk inducing dietary behavior is observed over time. This assumption 
implies that an individual’s diet over a period of time is the best indicator of risk.  
This assumption is consistent with dietary research [20].  
3. For a given time period, increased frequency of a risk inducing behavior is 
associated with increased risk, up to a maximum level. This assumption implies that 
the rate at which a risk-inducing behavior is performed is important, up to a 
maximum point at which saturation of the effect occurs.  
4. For a given frequency, the effect of a risk inducing dietary behavior is proportional 
with time, up to a maximum level. This assumption implies that a maximum level of 
increased risk exists.  This assumption ensures that the probability of a negative 
outcome never reaches 1. 
The development of the relative risk model is based on the above assumptions as well as 
interpolation from published data.  Plotting the relative risks (and their respective 95% 
confidence intervals) found by Schulze, et al. against the midpoint of the associated consumption 
range of sugar-sweetened beverages, a strong linear relationship is observed as presented in 
Figure 1.1.  The data covers an eight year time span of follow-up.  
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Figure 1.1. Observed relationships between relative risk of diabetes and frequency of 
sugar-sweetened beverage consumption, plotted with 95% confidence intervals. 
 
 
Following the assumptions about the nature of risk-inducing behavior and the observed 
linear relationship between consumption frequency and increased relative risk, the following 
relative risk model is proposed.  The relationship between relative risk and monthly consumption 
frequency is linear for all consumption time periods.  When no sugar-sweetened beverages are 
consumed (0 years of consumption), a constant relative risk of 1 is present.  For ten years of 
consumption, the relative risk for a given monthly consumption frequency follows the upper 
bound found in the research.  The slope of the line relating relative risk to monthly consumption 
frequency increases proportionally, up to the ten year slope at which point no further increase in 
relative risk is observed.  A decrease in consumption for a year likewise reduces the slope, down 
to a minimum of 0.  This model is illustrated in Figure 1.2.  
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Figure 1.2.  The relative risk model relating sugar-sweetened beverage 
consumption over time to increased relative risk of diabetes. 
 
 
 
The development of a model relating relative risks to personal decisions is necessary for 
the subsequent quantification of changes in lifetime prospects.  The development of the model 
valuing personal decisions is not dependent on a single relative risk model.  While the approach 
presented here adheres to plausible assumptions and relationships derived from published 
research, the experiments to determine its validity have not been done.  Further research is 
required in this area.  If adjustments to the relative risk model are found necessary, they can be 
easily incorporated into the personal decision model.  
 
 
1.4  BASELINE RISK OF DIABETES 
 In order to apply the relative risks derived above to a decision model, the underlying 
hazard function must be known.  The hazard function that is used throughout is drawn from risks 
calculated by Narayan et al. [21].  The risks are derived from a Markov model multiple sources 
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of U.S. data.  Figure 1.3 below illustrates the cumulative lifetime risk of diabetes mellitus for 
male and females, all races.  Note that the risk of diabetes levels off after age 80.  Thus, in the 
personal decision valuation model, the maximum age considered is 80 years.  
The risk of diabetes for an individual is determined as the product of the absolute risk and 
the relative risk according to the Cox proportional hazards model.   
 
 
Figure 1.3. The Cumulative lifetime risk of diabetes mellitus by gender. 
   
 
1.5  MORTALITY AND DIABETES 
 Diabetes increases an individual’s risk of death and is reported as the seventh leading 
cause of death in the U.S. [1]. Researchers have found that diabetes raises the risk of mortality by 
cancer by factor of 1.25 and increases the risk of mortality by vascular causes by a factor of 2.3 
[22].  Other researchers have found that diabetes increases an individual’s risk of death from any 
cause by as much as a factor of 2.5 [23].  The Centers for Disease Control and Prevention report 
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
20 30 40 50 60 70 80C
um
ul
at
iv
e 
L
if
et
im
e 
R
is
k
Age
Lifetime Risk of Diabetes
Female
Male
9 
 
that the mortality rate for individuals with diabetes is approximately twice that of individuals 
without diabetes [1].  This value is used in the lifestyle decision valuation model.  
 Calculating the costs of lifestyle decisions will require the probability of dying in a given 
year conditional on the individual being alive at the beginning of that year.  These probabilities 
are known as age-specific mortality rates.  Their baseline values in the U.S. can be obtained from 
the U.S. Department of Health and Human Services [24].  However, because the mortality rates 
reported include mortality of individuals with diabetes, simply multiplying the probability of 
dying in a given year by a factor of 2 will lead to an over estimation of mortality rates for 
individuals with diabetes.  Some calculations are necessary. 
 Let us consider a single year of mortality data.  In this year, the total number of 
individuals of age a who die is given by .  This total number of deaths is the sum of the 
number of deaths of individuals of age a with diabetes, , and those without diabetes, .  
 	    
Letting and  represent the total number of individuals alive at the beginning of the year 
with and without diabetes, respectively, and considering that the probability of dying at age a, 
, is the number of respective deaths divided by the total individuals alive at the beginning of 
the year, we arrive at the following equation. 
 	      
Given also a relationship between the mortality rate of individuals with and without diabetes, the 
relative risk at age a denoted by , the following equation can be written.  
 	 
 
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The values , , , and  are all available in the literature.  The only remaining 
quantities to solve for are  and , which can then be used to calculate the probability of 
dying at age a for those with and without diabetes according to the following equations.  
 	  	
      
 	  	
      
The difference in mortality between individuals of a given age with and without diabetes will 
play an important role when determining the value over lifetime prospects that differ in length of 
life.  
 
1.6  LIFE TABLE CALCULATIONS 
 In addition to the age-specific mortality rates discussed in the previous chapter, it is 
important to know the probability of an individual dying in all future years conditional on current 
age.  These probabilities are for a given age, and do not update for each year the individual 
survives.  As such, they sum to one and will be used to calculate expected medical costs once an 
individual is diagnosed with diabetes.   
The age-specific mortality rates already calculated are used to determine the probability 
of dying at all future ages.  Let these values be denoted in terms of the variable x where q(x) is 
the age specific-mortality at age x.  The survival function, S(x), gives the fraction of individuals 
in the cohort who are alive at age x, and is calculated as 
 	 
  !"

# 
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The failure function is the cumulative fraction of individuals who have not survived to age x and 
can be defined in terms of S(x) as 
$ 	 %   
The failure function is a cumulative probability distribution.  The probability of dying in all 
future years is the probability density function determined from F(x) and is 
& 	 
  !"

# 
Because the failure function begins at age 0 but the decision makers that will be considered here 
are all at least 25 years old, the distributions must be rescales so that the probabilities sum to one. 
 
1.7  MEDICAL COST OF DIABETES   
 The lifestyle decision valuation model considers the effects of decision making on direct 
medical costs.  The overall cost of diabetes is estimated to have reached at least $174 billion in 
2007 [25].  This figure includes both increased medical expenditures ($116 B) and lost 
productivity ($58 B), with the average increase in direct medical costs attributable to diabetes 
being $6,649 per year [25].  This figure is estimated for uncomplicated cases of diabetes.  When 
medical complications develop as a result of diabetes, this annual figure rises.  
 The framework presented in this thesis makes some simplifications concerning the 
analysis of medical costs.  Given a diagnosis of diabetes, the annual direct medical costs are 
treated as deterministic instead of probabilistic.  Uncertainty still remains in the models, 
however, as a result of the uncertainties surrounding a diagnosis of diabetes.   
 The actual medical costs incurred may differ from those estimated in the literature, 
leading to sources of error. It is possible that individuals do not seek recommended care 
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following a diagnosis.  In this case, it is likely that the individual will seek care once his or her 
condition deteriorates to a sufficient degree, at which point the medical costs may be greater.  
It is also possible that an individual will develop medical complications related to 
diabetes that greatly increase annual costs.  Because the model does not take into account the 
increasing probability of developing complications over time, it likely presents an 
underestimation of the medical costs incurred. 
Additional costs are present in the form of lost wages, productivity, or costs that are not 
directly medical in nature.  Again, the model will necessarily present an underestimation of the 
true costs associated with diabetes.  This trend is important to consider when drawing insights 
from the model analysis. 
 
1.8  RESEARCH QUESTIONS 
 Through the development of a framework to analyze the value of personal decision 
making, this thesis will address two central research questions. 
1. What additional expected medical costs are associated with the personal decision to 
consume sugar-sweetened beverages? How are these costs affected by different 
frequencies of consumption? 
2. What effect does risk aversion have on the certainty equivalent of medical costs 
associated with sugar-sweetened beverage consumption? 
The following chapter presents a normative framework for answering these questions.  
The subsequent chapters present the model, its analysis, and discussion. 
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2. THE DECISION TREE MODEL 
 
2.1 INTRODUCTION 
Personal decision making has a tremendous impact on life outcomes, including the 
probability of being diagnosed with diabetes [2].  The role of personal decision making in the 
prevention of diabetes, a condition with serious health implications, motivates the development 
of a normative decision making model describing the value of these decisions in terms of effects 
on expected lifetime medical costs.   
A diagnosis of diabetes has many effects on an individual’s life prospects.  This model 
focuses on the effects on lifetime medical costs because it enables insightful analysis on the cost 
of drinking sugar-sweetened beverages.  Such insights are useful in many applications, such as 
planning public health awareness campaigns or in better understanding the growth in health care 
spending in the U.S.  
The personal decision making model described in this chapter is based on the decision to 
consume sugar-sweetened beverages but also provides a framework for analyzing any decision 
that affects one’s risk of diabetes.  Thus the model is not limited to sugar-sweetened beverage 
decisions.  Any choice or behavior that increases one’s relative risk of developing diabetes can 
be analyzed once the degree to which the decision increases one’s risk is specified.   
This chapter describes the structure of the framework proposed for determining the effect 
of deciding to consume sugar-sweetened beverages on lifetime medical costs.  The chapter is 
structured as follows.  Section 2.2 describes the important distinctions in the model and their 
respective uncertainties.  Section 2.3 explains the decision tree.  Section 2.4 describes the 
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calculations necessary based on the given decision tree.  Section 2.5 discusses implications of 
some of the assumptions that are made.  
 
2.2 DISTINCTIONS AND UNCERTAINTIES 
In calculating the expected lifetime medical costs associated with the decision to 
consume sugar-sweetened beverages, several distinctions and their respective probabilities are 
important.  The important distinctions are, for a given year, whether the individual is alive, and if 
he is alive, whether he has been diagnosed with diabetes.  Let the event that the decision maker is 
alive in year j be denoted as '(, and the event that the decision maker is not alive in year j 
denoted by ') .  Furthermore, let the event that the decision maker is diagnosed with diabetes in 
year j be denoted by *( , and the event the decision maker is not diagnosed with diabetes in year j 
denoted by *) .  Note that both *(  and *)  are conditional on the decision maker being alive in 
year j. 
The uncertainties associated with the events '( and *( are also important.  Given that the 
decision maker was alive in year j, the probability of '(+,, the event that the decision maker is 
alive in year j+1, is denoted by pj+1.  Conversely, the probability of its complement, ') , is given 
by 1-pj+1, conditional on the decision maker being alive in year j.  The values of pj+1 for each age 
are derived from the National Vital Statistics Reports [24] and the mortality calculations derived 
in Section 1.5.  These values are also known as the age-specific risks of death.  Because the 
decision maker has not been diagnosed with diabetes, these probabilities are those calculated for 
an individual without diabetes.  
The uncertainties associated with *( are conditional on the event that the decision maker 
has not previously been diagnosed with diabetes and that the decision maker is alive in year j.  
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Given these events, the probability of being diagnosed with diabetes in year j is denoted !(, and 
its complement, the probability of not being diagnosed with diabetes in year j is denoted !) .  
These values are drawn from the risks calculated in literature [21] and are modified according to 
the relative risk model discussed in Chapter 1.  Recall that the relative risk of diabetes increases 
with sugar-sweetened beverage consumption [16, 17, 18].  This increase in risk causes the 
differentiation between the decision alternatives over sugar-sweetened beverage consumption.  
It is worthwhile to note that the decision maker is assumed to be an individual who has 
not had a prior diagnosis of diabetes or of pre-diabetes.  The probabilities developed herein 
follow this assumption.  It is assumed that any individual who is diagnosed with diabetes follows 
the advice of his or her physician. 
 
2.3 DECISION TREE 
Decision trees are useful tools for graphically displaying the uncertainties, events, and 
possible outcomes of a given decision situation and are used here to illustrate the framework 
developed. 
The model calculates the value of personal decisions based on the expected medical costs 
associated with that decision.  Thus, only the negative consequences of each decision alternative 
are considered.  As such, in this formulation, the decision not to consume sugar-sweetened 
beverages dominates the decision to consume them because the satisfaction and enjoyment of 
consumption are not included on the decision tree.  Both the decision to consume and not to 
consume must be included, however, in order to determine the increase in costs due to a given 
decision alternative.   The expected medical costs associated with each alternative are calculated, 
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and the value of a particular decision alternative is the difference in costs between that 
alternative and the alternative with the minimum cost.  
The decision tree is framed as a choice of whether or not to consume sugar-sweetened 
beverages at a given frequency for the remainder of one’s life. Figure 2.1a illustrates all the 
possible alternatives faced by a decision maker, where n represents the frequency of sugar-
sweetened beverage consumption per month. 
                         
(a)                                                                       (b) 
Figure 2.1. The decision alternatives. 
(a) Considering consumption frequency. 
(b) Simplification to two alternatives. 
 
Alternatively, the decision tree can be simplified by only considering two alternatives at a 
time, to begin consumption of sugar-sweetened beverages at a given frequency at age j, denoted 
by -(, or not to consume sugar-sweetened beverages for the remainder of one’s life, denoted by 
-) .  This simplification is illustrated in Figure 2.1b.   
 Given these alternatives, and the previously described distinctions and uncertainties, the 
full decision tree is derived using a sequential approach from age j through age 80.  The decision 
maker chooses to begin consumption or not in year j. In the first year, the relative risk of diabetes 
is unaffected.  At the start of year j+1, the decision maker is either still alive or not.  Given that 
-./0123/42./5
-./0123642./5
-./0123/  %42./5
…
-(
-( 
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the decision maker is alive, he can either be diagnosed with diabetes or not.  If after choosing 
alternative C, he is diagnosed with diabetes at age j+1, he faces expected medical costs, 
789(+,, over his future life prospects.  If he is not diagnosed, he progresses to year j+2 where 
he again faces uncertainties over being alive or not and over being diagnosed with diabetes or 
not.  Figure 2.2 illustrates the full decision tree, and Table 2.1 provides a summary of the 
notation for reference.  
 
Figure 2.2. The decision tree illustrating the sequential uncertainties and events 
associated with the decision to consume sugar-sweetened beverages or not. 
 
The sequential approach to the decision tree only continues through age 80 because the 
absolute risk of diabetes approaches zero at this age [21].  Once age 80 has been reached, the 
decision maker either has been diagnosed with diabetes or not and lives the remainder of his life 
in either of these two states.  The remainder of life is considered through age 99.  At this point, 
the probability of living longer than this is truncated in the probabilities considered.   
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<= The alternative to begin a given frequency of consumption of sugar-
sweetened beverages from age j onward 
<>  The alternative to not consume sugar-sweetened beverages from age j 
onward 
?= The event that the decision maker is alive in year j, given that he was alive 
in year j-1 ?>@@@ The event that the decision maker is not alive in year j, given that he was 
alive in year j-1 
A= The probability that the decision maker is alive in year j, given that he was 
alive in year j-1 
B= The event that the decision maker is diagnosed with diabetes in year j, 
given that he is alive in year j and has not previously been diagnosed 
B>@@@ The event that the decision maker is not diagnosed with diabetes in year j, 
given that he is alive in year j and has not previously been diagnosed 
C= The probability that the decision maker is diagnosed with diabetes in year 
j, given that he is alive in year j and has not previously been diagnosed 
D<E= The expected lifetime medical costs associated with choosing alternative C 
and being diagnosed with diabetes at age j 
D<E The expected lifetime medical costs due to diabetes associated with 
choosing alternative -; 
Table 2.1. The notation used in the decision tree. 
 
2.4 CALCULATIONS 
The calculations determine the expected lifetime medical costs due to diabetes as 
mediated by a choice of behavior, such as drinking a sugar-sweetened beverage, are performed in 
stages.  First, given a diagnosis of diabetes at age k, the expected medical costs for the future life 
prospect are calculated.  Second, the probability of being diagnosed with diabetes at age k is 
calculated. Given these values, the overall expected lifetime medical costs attributable to the 
choice of behavior are determined. 
Given the diagnosis of diabetes at age k, the expected future lifetime medical costs due to 
diabetes are calculated as illustrated in Figure 2.3.  The lifetime medical costs incurred by 
diabetes depend on the age at which diabetes is diagnosed as well as on the age of death.  Annual 
medical costs due to diabetes are assumed to be deterministic and constant, with an annual value 
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of $6,649 [25].  Given the age of diagnosis, k, and the age of death, i, the lifetime medical costs 
due to diabetes are denoted as -.0FG and calculated as  
HHIJK  L 
The probability of dying in a future year i, where i >k, conditional on the decision maker being 
alive and diagnosed with diabetes in year k, is denoted by qi where M G 	 %NNG .  These 
probabilities are calculated based on mortality data from the National Vital Statistics Reports 
[24], the mortality calculations derived in Section 1.5, and the life table calculations described in 
Appendix B.  Note that these probabilities are based on the mortality for an individual with 
diabetes, and that these mortality rates are double those for individuals without diabetes [1].  
Given the additional medical costs associated with death at each age, the expected future lifetime 
medical costs due to diabetes are calculated as 
OG-.0FG
NN
GPF
 
These expected lifetime medical costs associated with choosing alternative C and being 
diagnosed with diabetes at age k are denoted 789F.  
 
Figure 2.3. Calculating expected lifetime medical costs 
due to diabetes with diagnosis at age k. 
q99
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The probability of being diagnosed with diabetes at age k is next determined.  The 
probability of being diagnosed, conditional on the decision maker being alive and on not having 
been previously diagnosed, is determined as the product of the baseline risk of diabetes and the 
relative risk based on the individual’s decision as described in Chapter 1.  To determine the 
unconditional probability of being diagnosed at age k, R*F, the following equation is used 
R*FS'F *FT,@@@@@@R'FS'FT,R'FT,R*FT,@@@@@@ 
The probability of 'FT, and *FT,@@@@@@ is calculated as  
UR'VR*V@@@
FT,
VP(
 
where j is the age at which the individual makes a decision to consume sugar-sweetened beverages or not.  
These probabilities are calculated recursively, beginning with the fact that the decision maker is alive in 
year j, so that RW'(X 	 %, and also that the decision maker does not have diabetes in year j, so that 
RW*) X 	 %. 
 Once the values of R*F are determined, the expected lifetime medical costs due to diabetes are 
the summation of the product of these probabilities by their respective expectations, 789F.  If no 
diagnosis of diabetes is made, then the additional medical costs due to diabetes are zero. 
 Finally, the expected lifetime medical costs due to the decision to consume sugar-sweetened 
beverages is calculated as the difference of the expected costs when the decision maker chooses to 
consume the beverages and when the decision maker chooses to abstain from consumption.  The increase 
in cost is mediated by the increase in the relative risk of diabetes associated with the behavior.  It is 
important to note that this model calculates the costs associated with a choice of behavior, not the 
expected lifetime medical costs due to diabetes.  
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2.5 DISCUSSION 
The simplifying assumptions used in calculating the expected medical costs will have 
certain implications on the results.  Because the additional medical costs due to complications of 
diabetes are not considered, the costs derived by this model will likely be underestimated.  These 
costs provide useful lower bounds on costs.  Additionally, sensitivity analysis to the average 
annual cost provides additional insight.  
 The model presented in this chapter enables insightful analysis into the cost associated 
with the personal decision to consume sugar-sweetened beverages.  The framework is also 
widely applicable for any decision that impacts one’s risk of developing diabetes.   
 The insights that may be derived include the impact of age at which one begins 
consuming sugar-sweetened beverages on the expected lifetime cost of the decision.  The effect 
of relative risk and average annual medical costs due to diabetes can also be examined.  Chapter 
3 presents these analyses as well as other insights.  
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3. MEDICAL COSTS OF LIFESTYLE DECISIONS 
 
3.1 INTRODUCTION 
The cost of diabetes to society is estimated to have reached $117 billion in 2007 with 
increased direct medical costs of $116 billion [25].  The role of lifestyle decisions in the 
development of diabetes motivates the development of a model to determine the increase in 
expected lifetime medical costs associated with individual lifestyle decisions. Chapter 2 
describes this model as applied to decisions on whether to consume sugar-sweetened beverages 
at a given frequency for the remainder of one’s life.  This problem formulation allows a variety 
of insightful analyses into the cost of personal decision making, and specifically, the cost of 
consuming sugar-sweetened beverages.   
The distinction between the cost of diabetes and the cost of decision making is important.  
This model calculates the added expected cost as a result of lifestyle decision making.  The 
values presented are not the total expected medical costs of diabetes for an individual.   
Several parameters affect the expected lifetime costs associated with lifestyle decision 
making.  For example, the age at which an individual decides either to begin consuming sugar-
sweetened beverages or to abstain from consumption for the remainder of her life affects the 
number of years over which risks are increased.  The frequency of sugar-sweetened beverage 
consumption also affects one’s relative diabetes risk and thus expected costs.  This chapter 
examines the effect of these parameters. 
Model assumptions also affect the calculations, and the values of all inputs may not 
always be precisely known.  Sensitivity analysis highlights how these factors influence expected 
medical costs. 
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This chapter presents the analysis of the model and answers several questions.  Section 
3.2 describes the increases in expected medical costs and how they are affected by both the 
decision maker’s age and the frequency of consumption that is chosen.  Section 3.3 examines the 
effect of relative risk.  Section 3.4 explores the impact of changes in the average annual medical 
costs due to diabetes. 
 
3.2 EXPECTED MEDICAL COSTS 
The increase in expected medical costs due to sugar-sweetened beverage consumption is 
affected by both the age of the decision maker and the frequency of consumption that is chosen.  
These results are intuitive.  By beginning sugar-sweetened beverage consumption at a later age, 
more years have passed without an increased risk.  With fewer years of increased risk, and fewer 
expected years of life remaining over which to incur expenditures, the costs are reduced.  The 
effect of the frequency of sugar-sweetened beverage consumption follows from the relationship 
between changes in consumption level and changes in relative risk. This change in risk for 
diabetes mediates changes in expected medical expenditures.  Note also that other factors such as 
age and race affect one’s baseline risk of diabetes and mortality risks, and thus the expected cost 
of lifestyle decisions.  This section presents the expected lifetime medical costs due to sugar-
sweetened beverage consumption specifically for females, all races.  
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Figure 3.1. The cost of choosing to consume 1 sugar-sweetened beverage per day, by age. 
 
The cost of beginning consumption of one sugar-sweetened beverage per day, as 
measured by increased lifetime medical expenditures, is $33,458 for a 25 year old female, 
$24,850 for a 35 year old female, $14,853 for a 45 year old female, and $6,634 for a 55 year old 
female.  Figure 2.1 illustrates these differences.  A 25 year old who postpones consumption of 
one drink per day until she is 35 years old saves $8,608 in expected medical expenditures.  
Delaying consumption until she is 55 years old saves $26,825 in expected cost.  These results 
indicate that the cost of sugar-sweetened beverage consumption by young individuals is 
significantly greater than that of consumption by older individuals, and suggest that delaying 
consumption of sugar-sweetened beverages can yield significant savings in expected costs.  
An individual may also choose to begin sugar-sweetened beverage consumption at a 
lower frequency than one per day which will result in a lower relative risk according to the 
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relative risk model discussed in Chapter 1.  The effect of consumption frequency depends on the 
age of the individual.  These results are presented in Figure 3.2.  For a 25 year old, the difference 
in expected medical costs between consuming one drink per day and consuming five per month 
is $27,413.  For a 55 year old, the same difference in consumption level gives a cost difference 
of only $5,494, approximately one-fifth the savings of the 25 year old.  These results suggest that 
consuming sugar-sweetened beverages in moderation can yield considerable savings in expected 
lifetime medical costs, but that these savings are significantly greater for younger individuals. 
 
 
Figure 3.2. Increased expected medical costs by age and  
frequency of sugar-sweetened beverage consumption. 
 
 The effect on age is not linear.  This is a result of the nonlinearity of the baseline hazard 
function for diabetes as illustrated in Figure 1.3, as well as a result of the increasing relative risk 
for a time period after beginning consumption, up to the saturation point.   
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3.3 SENSITIVITY TO RELATIVE RISK 
An important input to calculating the cost of lifestyle decisions is the relative risk 
associated with these decisions.  Previous research has investigated the relative risks associated 
with consuming sugar-sweetened beverages [16, 17, 18].  These results form the basis of the 
relative risk model presented in Chapter 1 and used in this analysis.  Some of the research on the 
effects of sugar-sweetened beverages has come under criticism, particularly from the beverage 
industry [19].  In addition, some assumptions have been made in the relative risk model.  As 
such, it is important to understand how changes in the relative risk used in the model affect the 
calculated expected costs. 
As the relative risk of diabetes increases, so do the expected lifetime medical costs.  The 
effect is dependent on age as illustrated in Figure 3.3.  If the relative risk is 1, meaning that the 
risk is not increased over the baseline hazard, then the expected medical costs are zero.  The 
expected costs for all ages begin at this point.  As the relative risk increases, however, the effect 
is greater for younger individuals.  The difference in medical costs between age groups is more 
exaggerated as the relative risk increases.  
 
Figure 3.3. The effect of relative risk on expected medical costs, by age. 
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 The expected medical costs are increased even for small increases in the relative risk.  
For a relative risk of 1.25, the additional expected medical costs are $6,897 for a 25 year old, 
$5,850 for a 35 year old, $3,957 for a 45 year old, and $2,099 for a 55 year old.  Thus, even if the 
relative risks associated with sugar-sweetened beverages are lower than those reported in the 
literature, the expected lifetime medical costs due to sugar-sweetened beverage consumption are 
still sizable. 
 The effect of relative risk on expected lifetime medical costs is nonlinear.  As the relative 
risk increases, the increase in expected medical costs is not as great.  This relationship can be 
observed by plotting the slope of the increased costs against the relative risks as illustrated in 
Figure 3.4.  Overestimating the relative risk will impact the expected costs calculated, but as the 
overestimation increases, its effect will decrease.   
 
Figure 3.4. The rate of change in costs induced by changes in the relative risk. 
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calculating expected costs beyond those due to sugar-sweetened beverage consumption.  Other 
factors that increase one’s risk of diabetes that this model may be useful in analyzing include 
exercise level, body weight, and smoking.  
 
3.4 SENSITIVITY TO ANNUAL MEDICAL COSTS 
The additional expected medical expenditures calculated are based on the average annual 
cost of diabetes without complications.  These costs are treated as deterministic once an 
individual is diagnosed.  In reality, these medical costs may be variable, and will likely increase 
over time as complications develop due to diabetes.  These complications include amputation, 
blindness, renal failure, cardiovascular disease, peripheral vascular disease, and neurological 
symptoms.  Because none of these complications are taken into account, the calculated expected 
medical costs likely underestimate the true cost associated with lifestyle decisions. 
The effect of greater annual medical costs on the additional medical costs due to drinking 
one sugar-sweetened beverage per day is illustrated in Figure 3.5.   
If the annual medical costs attributable to diabetes increase from $6,649 to $10,000, then 
the cost of consuming a sugar-sweetened beverage per day increases to $50,321 for a 25 year 
old, $37,374 for a 35 year old, $22,339 for a 45 year old, and $9,977 for a 55 year old.   
The effect of increasing the annual medical costs in this model is linear due to the 
assumption that costs are deterministic following a diagnosis of diabetes.  The increased costs 
are multiplied by the same probabilities of life prospects when calculating the expected value.  
Thus it is possible to determine the increase in expected medical costs for each dollar that annual 
medical costs due to diabetes increases.  These results are displayed in Figure 3.6.  For a 25 year 
old, each dollar of annual spending on medical costs for diabetes increases expected costs by 
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over 5 times when consuming a sugar sweetened beverage each day.  For a 55 year old, each 
dollar increase in annual medical costs increases expected medical costs by just under a dollar. 
 
 
Figure 3.5. The effect of increased annual medical costs on medical  
expenditures due to drinking one sugar-sweetened beverage per day.  
 
 
Figure 3.6. Increase in expected costs due to a dollar increase in annual medical  
costs as a function of sugar-sweetened beverage consumption and age. 
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4. IMPLICATIONS AND FUTURE WORK 
 
4.1 IMPLICATIONS 
The model developed herein has several implications in various fields including 
insurance, public health campaigns, and national health care spending.  This section illustrates 
some of these implications in more detail. 
 
4.1.1  Insurance 
The previous work is of direct interest to insurance companies.  The purpose of insurance 
is to protect individuals from risks that they face in the future.  The insurance company needs to 
calculate the expected value of costs it will incur per individual insured.  It is well known that 
certain behaviors such as smoking lead to increases in life insurance levels due to the increase in 
relative risk.  This is why insurance companies analyze the effects of smoking on medical costs 
and charge a premium for smokers.  Similarly, the analysis shows how the consumption of a 
sugar-sweetened beverage each day increases expected lifetime medical costs.  For example, 
insurance companies can expect an increase in these costs equal to $33,000 for a 25 year old 
female. 
The level of co-insurance offered is also of interest.  The issue of moral hazard is well 
known in the medical insurance industry.  Moral hazard exists for individuals when they do not 
face the consequences of behaviors that lead to increased costs, such as the case with health 
insurance where some of the consequences of unhealthy behaviors are transferred to the 
insurance company.  For example, an individual knows whether or not he has decided to drink a 
sugar-sweetened beverage per day whereas the insurance company may not.  As such, he may 
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seek a higher level of insurance.  To combat this, insurance companies often do not offer 
insurance at 100% of costs, requiring the individual to share the burden of costs.  This practice is 
known as co-insurance and is used to reduce moral hazard.  Insurance companies can use the 
cost of lifestyle decisions to guide policies on co-insurance. 
 
4.1.2 National Health Care Spending 
Spending on medical care in the U.S. has been increasing dramatically for decades, with 
spending in 2008 reaching $2.3 trillion [26].  Given these trends, it would be significant to know 
how much of that spending is a result of lifestyle decisions.  The model and analysis presented in 
this thesis make such determinations possible. 
To calculate the expected costs in the United States that are a result of individual decision 
making, it is necessary to know how many individuals are consuming sugar-sweetened 
beverages and at what frequency.  Such research has been conducted using the National Health 
and Nutrition Examination Survey and found that on average, 63% of U.S. adults consume an 
average of 17 oz of sugar-sweetened beverages per day [27].  Using this statistic along with 2010 
US census data [28], it is possible to multiply the number of residents in each age category by 
the percentage who consume a sugar-sweetened beverage each day and by the expected medical 
costs that result.  For example, using ten-year age cohorts for the population, for ages 20-29, 30-
39, 40-49, and 50-59, and the expected medical cost of the midpoint age of each group, one finds 
that the expected medical costs due to sugar-sweetened beverage consumption, over the 80 years 
it takes for the youngest individual in this group to reach age 100, are $2.1 trillion.  This amount 
averages out to over $28 billion per year.  Note that this calculation assumes each individual only 
begins consuming sugar-sweetened beverages at the current age and does not account for 
previous consumption.  This calculation also only considers those adults who are between the 
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ages of 20 and 59 and does not consider costs accrued by individuals who are currently under 
age 20 and will become adults in the next 80 years. 
 
4.1.3 Public Health Awareness Campaigns 
   Public health awareness campaigns are used to educate the public about issues related to 
health that may be beneficial.  Education about behaviors that are within the public’s control can 
lead to improvement in health measures nationwide.  Being able to calculate the expected 
medical costs associated with lifestyle behaviors enables better planning for public health 
awareness campaigns.  For example, if it is known that the expected costs of a 25 year old 
beginning consumption of sugar-sweetened beverages is $33,458, then a campaign that costs less 
than $33,458 times the number of individuals who will stop their consumption as a result of the 
campaign will be cost effective.   
 
4.2   FUTURE WORK 
The model presented in this thesis calculates the expected medical costs that result from 
sugar-sweetened beverage consumption, and can also be used to calculate medical costs 
associated with any behavior that increases one’s relative risk of diabetes.  As shown in this 
chapter, this information is useful in a range of applications.  The model, however, can be further 
expanded to take into account additional factors including the effect of lifestyle decisions from a 
personal decision making perspective. 
Diabetes has a significant impact on the mortality rates faced by an individual.  These 
increased hazards are taken into account in calculating the years over which increased medical 
costs are incurred.  However, the loss of life itself is a significant alteration in the life prospects 
faced by an individual.  If one is interested in calculating the value of these decisions, outcomes 
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such as length of life that are of utmost importance to an individual must be taken into account.  
Howard has proposed a function to model tradeoffs between annual consumption, c, and length 
of life as measured as the ratio of life years remaining, l, to life expectancy Y ; [4].  Given a 
tradeoff parameter, η, and a risk aversion γ, the individual’s utility over life prospects becomes 
1Z Y 	 
 [\Z [Y Y ;] ^
_^ 
The framework for determining the cost of lifestyle decisions can be extended using a similar 
approach to determine the personal value of decision making.  Including the effect of decisions 
on length of life leads to the value of personal decisions because the individual will be facing the 
consequences of the decision, unlike the present calculation of expected medical costs which 
may or may not be borne by the individual.  The risk preferences and tradeoffs acceptable to the 
individual will be instrumental in determining the value to the decision maker. 
 The role of obesity also has a significant impact on life prospects.  Obesity is correlated 
with diabetes but also independently increases an individual’s risk of numerous negative 
outcomes, including medical costs and mortality among others [29].  Obesity, like diabetes, is 
strongly influenced by personal decision making, and is also linked to sugar-sweetened beverage 
consumption [16].  Additional analysis on medical costs as well as the value of personal decision 
making due to obesity is possible.  Including such considerations in the cost of the decision to 
consume sugar-sweetened beverages would likely increase the calculated expected costs.  Future 
work is needed to determine the magnitude of these costs as well as their wider implications.  
The results of this analysis that show significant costs associated with the decision to 
consume sugar-sweetened beverages should not be surprising.  Significant literature and 
warnings exist on the consumption of excess sugar in one’s diet as well as the consumption of 
sugar-sweetened beverages specifically.  These findings are so significant that petitions have 
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even been filed with the U.S. Food and Drug Administration requesting that warning labels be 
placed on beverages containing more than 1.1 gram of sugar per ounce [30].  The results of this 
model and analysis further indicate that significant costs are associated with sugar-sweetened 
beverage consumption. 
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